J Gynecol Oncol.  2019 Sep;30(5):e76. 10.3802/jgo.2019.30.e76.

Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling

  • 1National Cancer Control Institute, National Cancer Center, Goyang, Korea. jkjun@ncc.re.kr
  • 2Department of Medical Education and Medical Humanities, Graduate School, Kyung Hee University, Seoul, Korea.
  • 3Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • 4Center for Uterine Cancer, National Cancer Center Hospital, National Cancer Center, Goyang, Korea.
  • 5Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.


Human papillomavirus testing by self-sampling and urine sampling might be alternatives to Papanicolaou test (Pap test) for cervical cancer screening (CCS), and may increase compliance and adherence thereto. The present study aimed to explore satisfaction and preferences for cervical screening modalities among Korean women.
In total, 732 women aged between 20 and 69 years responded to a questionnaire designed to survey the women's perceived satisfaction for the 3 CCS modalities: clinician-collected Pap test, self-collected vaginal sampling (self-sampling) and urine sampling.
Overall satisfaction was significantly higher with both the self-sampling and urine sampling than the clinician-collected Pap test (odds ratio [OR]=2.01; 95% confidence interval [CI]=1.48-3.00 and OR=2.47; 95% CI=1.75-3.48, respectively). Psychological distress, including embarrassment, pain, anxiety, discomfort, and stress, with self-sampling and urine sampling were significantly lower than that with the Pap test. 52% of participants reported preferences for self-sampling in the next screening round.
Korean women were more likely to report satisfaction with alternative modalities (self-sampling and urine sampling) for CCS in comparison to the Pap test. This suggests that self-collected modalities may help with improving CCS uptake rates by eliminating burden related with the Pap test. However, further studies for test accuracy and cost-effective analysis of the alternative modalities should be conducted in order to apply CCS.


Cervical Neoplasm; Cancer Screening; Human Papillomavirus DNA Test; Pap Test

MeSH Terms

Early Detection of Cancer
Mass Screening*
Papanicolaou Test*
Surveys and Questionnaires
Uterine Cervical Neoplasms*
Full Text Links
  • JGO
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr